‘Quadrapeutics’ works in preclinical study of hard-to-treat tumors

The first preclinical study of a anti-cancer technology found that a novel combination of existing clinical treatments can instantaneously detect and kill only cancer cells — often by blowing them apart — without harming surrounding normal organs. The researcher shows that Rice University's “quadrapeutics” technology was 17 times more efficient than conventional chemoradiation therapy against aggressive, drug-resistant head and neck tumors.

Provided by Rice University

Runtime: 2:13

Get Science360's video of the day in your mailbox each weekday.

Sign up now!